The BCW Index gained 2 percent for the week ended Tuesday, as 15 of the 16 companies in the Index either gained ground or were flat for the period. The upswing was consistent with gains realized by tech stocks during the week.
Bruker Biosciences led gainers with a 5-percent increase, followed by PerkinElmer, which rose 4.4 percent. The only firm in the Index to lose ground for the trading period was Stratagene, whose shares dropped 8.5 percent.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.